Nvidia Introduces RTX 50 Series Graphics Chips at CES 2025
January 7, 2025 - 02:06
Nvidia has officially launched its highly anticipated RTX 50 series of graphics chips during the CES 2025 event. This new lineup includes a range of powerful desktop and laptop graphics cards, with the flagship model, the RTX 5090, priced at $1,999.
The RTX 50 series promises significant advancements in gaming performance, featuring cutting-edge technology that enhances ray tracing capabilities and overall rendering quality. Gamers can expect smoother frame rates and more immersive experiences, thanks to the improved architecture and increased processing power of these new chips.
In addition to the RTX 5090, Nvidia has introduced several other models in the series, catering to a variety of gaming needs and budgets. The company emphasizes its commitment to pushing the boundaries of graphics technology, aiming to meet the demands of both casual and professional gamers alike. As the gaming landscape continues to evolve, Nvidia's RTX 50 series is poised to set new standards in visual fidelity and performance.
MORE NEWS
September 12, 2026 - 00:50
US Tariff Refunds Slow as Government Collects More Than It Pays OutThe flow of tariff refunds from the US government has slowed sharply, with new figures showing the Treasury took in more money from tariffs than it returned to importers for the first time in...
September 11, 2026 - 02:46
Rayonier Advanced Materials’ (RYAM) Pricing Power Is Surging, But Volumes Tell Another StoryRayonier Advanced Materials reported second-quarter results on August 4 for the period ending June 27, showing a mixed picture of financial performance. Net sales reached $376 million, an 18...
September 10, 2026 - 21:54
OpenAI Rolls Out ChatGPT for Financial Services With Major Industry PartnersOpenAI has introduced a version of ChatGPT built specifically for the financial sector, teaming up with several large brokerages and research organizations, including Morgan Stanley and S&P. The...
September 10, 2026 - 04:58
InMed Reports Full Year Fiscal 2026 Financial Results and Provides Corporate UpdateVancouver-based InMed Pharmaceuticals has released its financial results for the full fiscal year that ended on June 30, 2026, alongside a broader update on its corporate activities. The company,...